00000000cam 2200000zi 4500
0019.957044
003CaOODSP
00520260105161553
006m     o  d f      
007cr cn|||||||||
008251103e202511##oncado  ob   f000 0 eng d
020 |a9780660796000
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH22-4/46-2025E-PDF
24500|aFinal report of the National Pharmacare Committee of Experts 2025.
24617|aReport of the National Pharmacare Committee of Experts 2025
264 1|aOttawa, ON : |bGovernment of Canada = Gouvernement du Canada, |cNovember 2025.
264 4|c©2025
300 |a1 online resource (79 pages) : |billustrations, graphs, photographs
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aCover title.
500 |aIssued also in French under title: Rapport final du comité d'experts en matière d'assurance médicaments nationale 2025.
504 |aIncludes bibliographical references (pages 67-79).
520 |a"This report presents a comprehensive framework for universal, single-payer, publicly administered pharmacare in Canada. It is grounded in the recognition of access to essential medicines as a human right and will: close gaps in medication access, reduce health disparities, improve health outcomes, save billions of dollars"--Executive summary, page 6.
550 |aIssued by: Health Canada.
650 0|aPharmaceutical industry|xGovernment policy|zCanada.
650 0|aPharmaceutical services insurance|xGovernment policy|zCanada.
650 0|aPharmaceutical services|xGovernment policy|zCanada.
7101 |aCanada. |bHealth Canada, |eissuing body.
77508|tRapport final du comité d'experts en matière d'assurance médicaments nationale 2025.|w(CaOODSP)9.957045
85640|qPDF|s1.63 MB|uhttps://publications.gc.ca/collections/collection_2025/sc-hc/H22-4-46-2025-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/publications/health-system-services/report-national-pharmacare-committee-experts.html
986 |a250317